This summary was created by AI, based on 1 opinions in the last 12 months.
Experts have mixed opinions on the company Metlife with some suggesting that it could be a good time for investors due to its low valuation, while others believe that there are better options available. The stock is fundamentally rated 6/10 and could be volatile. Overall, the reviews indicate uncertainty and differing viewpoints on the potential of the company.
Metlife is a American stock, trading under the symbol MET-N on the New York Stock Exchange (MET). It is usually referred to as NYSE:MET or MET-N
In the last year, 1 stock analyst published opinions about MET-N. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Metlife.
Metlife was recommended as a Top Pick by on . Read the latest stock experts ratings for Metlife.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Metlife In the last year. It is a trending stock that is worth watching.
On 2024-04-25, Metlife (MET-N) stock closed at a price of $71.9.
Does not own shares. Financial services and insurance. Valuation is low and could be good time for investors. Does not own shares. Fundamentally a 6/10. Could be volatile. Better options out there for investors.